Skip to content
drillr.ai
Sign up

600771.SH

GuangYuYuan Chinese Herbal Medicine Co., Ltd.

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 13.51
−0.59%
Ask drillr

  • Oct 30, 2026, 09:20 UTC

    Guangyuyuan repurchased 414,300 shares for a total of RMB 5.0905 million, excluding transaction fees.

    Source:

  • Oct 29, 2026, 12:31 UTC

    Guangyuyuan announced plans to repurchase its shares for RMB 40 million to RMB 50 million for an employee stock ownership plan or equity incentives.

    Source:

  • Oct 28, 2026, 08:57 UTC

    Guangyuyuan reported revenue of 1.003 billion yuan for the first three quarters of 2026, down 5.42% year over year, and attributable net profit of 79.0652 million yuan, up 0.23%.

    Source:

  • Oct 28, 2026, 08:57 UTC

    Guangyuyuan reported third-quarter 2026 revenue of 179 million yuan, down 36.45% year over year, and attributable net loss of 5.5921 million yuan, compared with a profit a year earlier.

    Source:

  • Oct 13, 2026, 08:59 UTC

    Macau’s Pharmaceutical Administration Bureau issued a traditional Chinese medicine registration certificate for Angong Niuhuang Wan to Guangyuyuan’s subsidiary Shanxi Guangyuyuan National Medicine Co., Ltd.

    Source: